Also known as triiodothyronine.
Note: This product is not licenced in Australia at the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.
Trade name
Liothyronine (MercuryPharma)
Presentation and preparation
|
Vial size
(powder volume) |
Fluid to add
|
Volume to add
|
Resulting concentration
|
|---|---|---|---|
| 20 microgram (negligible) |
Water for injections | 2 mL | 10 microgram/mL |
IV administration
Give undiluted over 3 to 5 minutes.
May also be diluted and given as a continuous infusion; refer to local guidelines.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Sodium chloride 0.9%
Additional information
Continuous cardiac monitoring may be necessary.
Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.
Use a hard plastic syringe for administration and (brown tubing).
Significant loss of liothyronine occurs when diluted. Titrate doses to clinical response where appropriate.
Use immediately after reconstitution.
Protect from light during storage and administration. Cover syringe/bag with a light-excluding pouch or foil and by using brown tubing.